Morgan Stanley downgrades WebMD WBMD to Underweight on another disappointing guide, and establishes a $20 price target.
Morgan Stanley says, "Key concerns leading to our Underweight rating include: (1) Repeated guidance reductions, including a sharp deterioration in management's outlook between early November and early January. (2) Fear that WBMD may be losing share to more aggressive competitors. (3) Our forecasts imply a 7% Y/Y revenue decline and 25% Y/Y EBITDA decline in 2012, and just single-digit revenue growth beyond 2012, well below
WBMD's prior trend growth. (4) Still-elevated multiples: at $26, WBMD trades at 9X/8X our 2012E/2013E EBITDA, a premium to businesses that are growing in 2012 (DMD, EXPE, DRIV at around 5X EBITDA), and faster-growing businesses such as GOOG (9X/7X)."
WBMD closed at $26.25 per share on Tuesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in